Protocol for vision transformer-based evaluation of drug potency using images processed by an optimized Sobel operator
Conventional approaches for screening anticancer drugs rely on chemical reactions, which are time consuming, labor intensive, and costly. Here, we present a protocol for label-free and high-throughput assessment of drug efficacy using a vision transformer and a Conv2D. We describe the steps for cell...
Saved in:
Published in | STAR protocols Vol. 4; no. 2; p. 102259 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
16.06.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Conventional approaches for screening anticancer drugs rely on chemical reactions, which are time consuming, labor intensive, and costly. Here, we present a protocol for label-free and high-throughput assessment of drug efficacy using a vision transformer and a Conv2D. We describe the steps for cell culture, drug treatment, data collection, and preprocessing. We then detail the building of deep learning models and their use to predict drug potency. This protocol can be adapted for screening chemicals that affect the density or morphological features of cells.
For complete details on the use and execution of this protocol, please refer to Wang et al.1
[Display omitted]
•Protocol for label-free evaluation of drug potency using a vision transformer and a Conv2D•A cost-effective method for high-throughput screening of anticancer drugs•An adaptable method for screening molecules that affect cell density and shape
Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
Conventional approaches for screening anticancer drugs rely on chemical reactions, which are time consuming, labor intensive, and costly. Here, we present a protocol for label-free and high-throughput assessment of drug efficacy using a vision transformer and a Conv2D. We describe the steps for cell culture, drug treatment, data collection, and preprocessing. We then detail the building of deep learning models and their use to predict drug potency. This protocol can be adapted for screening chemicals that affect the density or morphological features of cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Technical contact These authors contributed equally Lead contact |
ISSN: | 2666-1667 2666-1667 |
DOI: | 10.1016/j.xpro.2023.102259 |